Project: Development of a sublingual mucosal immunization technology platform for needle-free vaccination

Acronym MucoVAC (Reference Number: 12830)
Duration 31/05/2019 - 02/06/2022
Project Topic The consortium will develop a novel platform technology for sublingual vaccination. This project will deliver a validated and widely applicable technology consisting of sublingual delivery method and sublingual adjuvant with demonstrated capacity to load it with different types of antigens. In addition, for one specific vaccine the consortium will perform the pre-clinical testing, to demonstrate the efficacy of this platform technology.
Network Eurostars 2
Call Eurostars Cut–off 10

Project partner

Number Name Role Country
1 InStar Technologies a. s. Coordinator Czech Republic
2 Helmholtz-Zentrum für Infektionsforschung GmbH Partner Germany
3 LiteVax BV Partner Netherlands
4 Timeline Bioresearch AB Partner Sweden
5 Chimera Biotec GmbH Partner Germany